Results 171 to 180 of about 20,467 (239)

Effects of Dexamethasone Intravitreal Implant on Multifocal Electroretinography in Diabetic Macular Oedema. [PDF]

Drug Des Devel Ther
Tranos P, Koukoula S, de Politis PB, Tranou M, Giamouridou O, Stavrakas P, Panos GD.   +6 more
europepmc   +1 more source

Development and validation of a 3-D deep learning system for diabetic macular oedema classification on optical coherence tomography images. [PDF]

BMJ Open
Zhu H, Ji J, Lin JW, Wang J, Zheng Y, Xie P, Liu C, Ng TK, Huang J, Xiong Y, Wu H, Lin L, Zhang M, Zhang G.   +13 more
europepmc   +1 more source

Eligibility for faricimab in a real-world diabetic macular oedema population: a cross-sectional study. [PDF]

BMJ Open
Westborg I, Al-Najjar A, Norberg H.
europepmc   +1 more source

Ranibizumab with luseogliflozin in type 2 diabetes with diabetic macular oedema: A randomised clinical trial. [PDF]

Diabetes Obes Metab
Ishibashi R, Takatsuna Y, Koshizaka M, Tatsumi T, Takahashi S, Nagashima K, Ishikawa K, Kaiho T, Asaumi N, Baba T, Yamamoto S, Yokote K, COMET Trial investigators.   +12 more
europepmc   +1 more source

Twelve-Month Outcomes of Faricimab for Patients with Sub-Optimally Responsive Diabetic Macular Oedema: A Retrospective Single-Centre Study. [PDF]

Clin Ophthalmol
El-Badawi K, Scrivens B, Eke O, Ismail R, Kobayter L, Salvatore S.   +5 more
europepmc   +1 more source

Baseline factors affecting diabetic macular oedema resolution after intravitreal dexamethasone implant treatment: post hoc analysis of the MEAD study. [PDF]

BMC Ophthalmol
Valentim CCS, Lai H, Ogidigben MJ, Singh RP, Talcott KE.   +4 more
europepmc   +1 more source

Impact of anti-VEGF treatment for diabetic macular oedema on progression to proliferative diabetic retinopathy: data-driven insights from a multicentre study. [PDF]

BMJ Open Ophthalmol
Olvera-Barrios A, Lilaonitkul W, Heeren TFC, Rozenberg A, Thomas D, Warwick A, Soomro T, Alsaedi A, Schwartz R, Chakravarthy U, Eleftheriadis H, Ghanchi F, Patwardhan A, Taylor P, Tufail A, A Egan C, UK DR EHR Users group, UK DR EMR Users group.   +17 more
europepmc   +1 more source

Study of Imaging Biomarkers as a Prognostic Factor and Guide in the Management of Diabetic Macular Oedema. [PDF]

Cureus
Shrivastava N, Som V, Kumar K.
europepmc   +1 more source

Anti-VEGFs for Diabetic Macular Oedema: Analysis of Efficacy, Safety, and Cost of More Durable Therapies from a Dutch Societal Perspective. [PDF]

Adv Ther
Quist SW, Paulissen JHJ, Lunk I, Carrasco J, Woudstra MA, Pochopien M, Nikodem M, Crossan C, Amarakoon S, van Asten F, Postma MJ.   +10 more
europepmc   +1 more source

Gender and ethnic diversity in randomised clinical trials in age-related macular degeneration and diabetic macular oedema. [PDF]

Eye (Lond)
Ibrahim FN, Sivaprasad S, Cheung CMG.
europepmc   +1 more source